Klinikum der Universität München

S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion (2023) Bitzer M, Groß S, Albert J, Boda-Heggemann J, Brunner T, Caspari R, De Toni E, et al. Journal article Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer – Results of a large multicenter analysis (2023) Roesch J, Oertel M, Wegen S, Trommer M, Schleifenbaum J, Hering D, Mäurer M, et al. Journal article Update Breast Cancer 2022 Part 6 – Advanced-Stage Breast Cancer (2023) Lüftner D, Lux MP, Fehm TN, Welslau M, Müller V, Schütz F, Fasching P, et al. Journal article, Review article Update Breast Cancer 2022 Part 5 – Early Stage Breast Cancer (2023) Fehm TN, Welslau M, Müller V, Lüftner D, Schütz F, Fasching P, Janni W, et al. Journal article, Review article Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study (2023) Salzmann M, Wald A, Stege H, Loquai C, Zimmer L, Hayani KM, Heinzerling L, et al. Journal article Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning (2023) Eckardt JN, Röllig C, Metzeler K, Kramer M, Stasik S, Georgi JA, Heisig P, et al. Journal article Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis (2023) Bodensohn R, Werner S, Reis J, Pazos Escudero M, Kaempfel AL, Hadi I, Forbrig R, et al. Journal article Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer - Controversies and Standards in Healthcare (2023) Müller V, Fasching P, Nabieva N, Fehm TN, Thill M, Schmidt M, Kühn T, et al. Journal article, Review article Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy response (2023) Madlener M, Strippel C, Thaler FS, Doppler K, Wandinger KP, Lewerenz J, Ringelstein M, et al. Journal article Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors (2023) Nuñez NG, Berner F, Friebel E, Unger S, Wyss N, Gomez JM, Purde MT, et al. Journal article